New clinical data from a second, large international study that enrolled "all comers," regardless of disease complexity and comorbidities, again demonstrated the strong performance of the Resolute drug-eluting stent (DES) from Medtronic,
The findings include one-year results for RESOLUTE International, two subsets from RESOLUTE All Comers, and four-year results for the RESOLUTE feasibility study, which supported the CE (Conformite Europeenne) mark of the Resolute DES.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment